AbbVie implemented an integration plan designed to reduce costs, integrate and optimize the combined organization and realized $2.5 billion of annual cost synergies in 2022; the company continues to closely manage manufacturing and supply chain resources around the world to help ensure that patients receive an uninterrupted supply of their medicines and monitors clinical trial sites locally to protect safety and trial integrity; AbbVie uses non-GAAP measures such as net revenues at constant currency rates to facilitate analysis of its results of operations and establishes rebate and chargeback accruals as variable consideration by leveraging internal and external data to estimate distribution channel inventory levels and claims processing lag times, regularly adjusting reserves based on evolving trends, contract terms and legislative changes; accounts receivable are monitored through customer communications, with allowances for credit losses recorded over receivable lives and factoring arrangements used to mitigate credit risk; contingent consideration liabilities are valued and remeasured to fair value at each reporting date using probability-weighted expected payment models, Monte Carlo simulations, forecasted sales volumes and discount rates; goodwill and indefinite-lived intangible assets are tested for impairment annually or upon triggering events through qualitative assessments and discounted cash flow analyses based on assumptions about volume, revenue and expense growth rates, working capital changes and discount rates; defined benefit pension and other post-employment obligations and costs are calculated by outside actuaries using key assumptions such as discount rates derived from high-quality bond yield curves, expected long-term rates of return on plan assets and health care cost trend rates; the company maintains a $4 billion five-year revolving credit facility maturing in 2024 to borrow on an unsecured basis at variable interest rates subject to covenants and leverages debt issuances, commercial paper programs and credit facilities to support liquidity; and income taxes are accounted for under the asset and liability method with deferred tax assets and liabilities recorded based on enacted tax rates, valuation allowances established when realization is uncertain, and one-time transition tax liabilities and unrecognized tax benefits disclosed.